BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fante MA, Holler B, Weber D, Angstwurm K, Bergler T, Holler E, Edinger M, Herr W, Wertheimer T, Wolff D. Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis. Ann Hematol 2020;99:2181-90. [PMID: 32715339 DOI: 10.1007/s00277-020-04193-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wertheimer T, Dohse M, Afram G, Weber D, Heidenreich M, Holler B, Kattner AS, Neubauer A, Mielke S, Ljungman P, Holler E, Herr W, Edinger M, Martínez AP, Fante M, Wolff D. Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis. Ann Hematol 2021;100:779-87. [PMID: 33515310 DOI: 10.1007/s00277-021-04434-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cuvelier GDE, Schoettler M, Buxbaum NP, Pinal-Fernandez I, Schmalzing M, Distler JHW, Penack O, Santomasso BD, Zeiser R, Angstwurm K, MacDonald KPA, Kimberly WT, Taylor N, Bilic E, Banas B, Buettner-Herold M, Sinha N, Greinix HT, Pidala J, Schultz KR, Williams KM, Inamoto Y, Cutler C, Md H, Lee SJ, Sarantopoulos S, Pavletic SZ, Wolff D. Towards a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force. Transplant Cell Ther 2022:S2666-6367(22)01334-3. [PMID: 35662591 DOI: 10.1016/j.jtct.2022.05.038] [Reference Citation Analysis]
3 Wolff D, Fatobene G, Rocha V, Kröger N, Flowers ME. Steroid-refractory chronic graft-versus-host disease: treatment options and patient management. Bone Marrow Transplant 2021;56:2079-87. [PMID: 34218265 DOI: 10.1038/s41409-021-01389-5] [Reference Citation Analysis]
4 Sobkowiak-sobierajska A, Lindemans C, Sykora T, Wachowiak J, Dalle J, Bonig H, Gennery A, Lawitschka A. Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan. Front Pediatr 2022;10:808103. [DOI: 10.3389/fped.2022.808103] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]